Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Prostatic Neoplasms"" wg kryterium: Temat


Tytuł :
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
Autorzy :
Fan L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Fei X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhu Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pan J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sha J; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Chi C; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gong Y; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Du X; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhou L; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Dong B; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Xue W; Department of Urology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Feb; Vol. 205 (2), pp. 461-469. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Sequence Analysis, DNA*
Circulating Tumor DNA/*blood
Circulating Tumor DNA/*genetics
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*genetics
Aged ; Androgen Antagonists/therapeutic use ; Genomics ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/genetics ; Retrospective Studies
Czasopismo naukowe
Tytuł :
PROACTA: a survey on the actual attitude of the Italian radiation oncologists in the management and prescription of hormonal therapy in prostate cancer patients.
Autorzy :
Fersino S; Radiation Oncology Department, Azienda Provinciale per i Servizi Sanitari, Ospedale S.Chiara, Largo Medaglie d'oro, 9, 38122, Trento, Italy. .
Borghesi S; Radiotherapy Unit- Ospedale S. Donato e Santa Maria alla Gruccia, Azienda USL Toscana Sud, Arezzo, Italy.
Jereczek-Fossa BA; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy.
Arcangeli S; UOC Radioterapia ASST Monza, Università di Milano, Bicocca, Italy.
Mortellaro G; Department of Radiation Oncology, ARNAS Ospedale Civico, Palermo, Italy.
Magrini SM; Department of Radiation Oncology, University and Spedali Civili Hospital, Brescia, Italy.
Alongi F; Advanced Radiation Oncology Department, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar-Verona, Italy.; University of Brescia, Brescia, Italy.
Pokaż więcej
Corporate Authors :
Uro-Oncology study group of Italian association of Radiotherapy and Clinical Oncology (AIRO)
Źródło :
La Radiologia medica [Radiol Med] 2021 Mar; Vol. 126 (3), pp. 460-465. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Journal Article
MeSH Terms :
Attitude of Health Personnel*
Radiation Oncologists*
Androgen Antagonists/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Health Care Surveys/*statistics & numerical data
Prostatic Neoplasms/*drug therapy
Androstenes/therapeutic use ; Combined Modality Therapy/methods ; Gonadotropin-Releasing Hormone/agonists ; Humans ; Italy ; Male ; Phenylthiohydantoin/analogs & derivatives ; Phenylthiohydantoin/therapeutic use ; Prostatectomy ; Prostatic Neoplasms/radiotherapy ; Prostatic Neoplasms/surgery ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/radiotherapy ; Risk Factors ; Salvage Therapy/methods
Czasopismo naukowe
Tytuł :
Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Autorzy :
Xu MC; Vanderbilt University School of Medicine, Nashville, Tennessee.
Huelster HL; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Hatcher JB; Vanderbilt University School of Medicine, Nashville, Tennessee.
Avulova S; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Stocks BT; Vanderbilt University School of Medicine, Nashville, Tennessee.
Glaser ZA; Vanderbilt University School of Medicine, Nashville, Tennessee.
Moses KA; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Silver HJ; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Mar; Vol. 205 (3), pp. 800-805. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Obesity/*complications
Prostatic Neoplasms/*pathology
Sarcopenia/*complications
Adipose Tissue/diagnostic imaging ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Muscle, Skeletal/diagnostic imaging ; Neoplasm Metastasis ; Neoplasm Staging ; Obesity/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/pathology ; Retrospective Studies ; Sarcopenia/diagnostic imaging ; Survival Rate ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Treating Prostate Cancer by Antibody-Drug Conjugates.
Autorzy :
Rosellini M; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Santoni M; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Mollica V; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Rizzo A; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cimadamore A; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Scarpelli M; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Storti N; Direzione Sanitaria Azienda Sanitaria Unica Regionale, 60122 Ancona, Italy.
Battelli N; Oncology Unit, Macerata Hospital, 62100 Macerata, Italy.
Montironi R; Section of Pathological Anatomy, School of Medicine, United Hospitals, Polytechnic University of the Marche Region, 60126 Ancona, Italy.
Massari F; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Feb 04; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents, Immunological/*therapeutic use
Immunoconjugates/*therapeutic use
Prostatic Neoplasms/*drug therapy
Animals ; Antineoplastic Agents, Immunological/pharmacology ; Biomarkers, Tumor ; Clinical Trials as Topic ; Disease Management ; Disease Susceptibility ; Humans ; Immunoconjugates/pharmacology ; Male ; Molecular Targeted Therapy ; Prognosis ; Prostatic Neoplasms/etiology ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/etiology ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Standard of Care ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Contemporary management of advanced prostate cancer: an evolving landscape.
Autorzy :
Khanna A; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
O'Connor LP; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Murthy PB; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Bryk DJ; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Fascelli M; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Ericson K; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Yerram NK; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Haywood SC; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Abouassaly R; Glickman Urologic and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Pokaż więcej
Źródło :
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Feb; Vol. 19 (2), pp. 108-118.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Therapies, Investigational*
Adenocarcinoma/*therapy
Prostatic Neoplasms/*therapy
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Androstenes/therapeutic use ; Benzamides/therapeutic use ; Clinical Trials as Topic ; Combined Modality Therapy ; Diagnostic Imaging/methods ; Disease Management ; Docetaxel/therapeutic use ; Humans ; Male ; Multicenter Studies as Topic ; Nitriles/therapeutic use ; Phenylthiohydantoin/therapeutic use ; Precision Medicine ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/therapy ; Radiotherapy, Adjuvant ; Radium/therapeutic use ; Taxoids/therapeutic use
Czasopismo naukowe
Tytuł :
Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1.
Autorzy :
Zhang Y; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Chen B; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xu N; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Xu P; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Lin W; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Liu C; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Huang P; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Guangzhou Key Laboratory of Inflammatory and Immune Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Pokaż więcej
Źródło :
International journal of nanomedicine [Int J Nanomedicine] 2021 Jan 12; Vol. 16, pp. 315-327. Date of Electronic Publication: 2021 Jan 12 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Androgens/*pharmacology
Exosomes/*metabolism
Heme Oxygenase-1/*metabolism
Prostatic Neoplasms/*pathology
Up-Regulation/*drug effects
Animals ; Cell Line, Tumor ; Disease Progression ; Exosomes/ultrastructure ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice, Inbred NOD ; Mice, SCID ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms, Castration-Resistant/genetics ; Prostatic Neoplasms, Castration-Resistant/pathology ; Receptors, Androgen/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
4,4'-Diisothiocyanatostilbene-2,2'-disulfonate modulates voltage-gated K current and influences cell cycle arrest in androgen sensitive and insensitive human prostate cancer cell lines.
Autorzy :
George K; Department of Biomedical Engineering, Chennai Institute of Technology, Chennai, India.; Bio Engineering Lab, Department of Electronics and Instrumentation Engineering, Annamalai University, Annamalai Nagar, India.
Thomas NS; Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, India.
Malathi R; Bio Engineering Lab, Department of Electronics and Instrumentation Engineering, Annamalai University, Annamalai Nagar, India.
Pokaż więcej
Źródło :
Toxicology mechanisms and methods [Toxicol Mech Methods] 2020 Jun; Vol. 30 (5), pp. 358-369. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms*/pathology
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/*pharmacology
Antineoplastic Agents/*pharmacology
Cell Cycle Checkpoints/*drug effects
Potassium Channel Blockers/*pharmacology
Potassium Channels, Voltage-Gated/*antagonists & inhibitors
Receptors, Androgen/*metabolism
Apoptosis/drug effects ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Humans ; Male ; Membrane Potentials/drug effects ; PC-3 Cells ; Patch-Clamp Techniques ; Potassium Channels, Voltage-Gated/metabolism ; Prostate/drug effects ; Prostate/metabolism ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/pathology ; Tetraethylammonium/pharmacology
Czasopismo naukowe
Tytuł :
Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
Autorzy :
Jakob T; Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Tesfamariam YM; Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Macherey S; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cochrane Haematological Malignancies, Cologne, Germany.
Kuhr K; Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Adams A; Institute of Medical Statistics and Computational Biology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Monsef I; Cochrane Haematology, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Heidenreich A; Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Department of Urology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Skoetz N; Cochrane Cancer, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Dec 03; Vol. 12. Cochrane AN: CD013020. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Bone Density Conservation Agents/*therapeutic use
Bone Neoplasms/*drug therapy
Bone Neoplasms/*secondary
Denosumab/*therapeutic use
Diphosphonates/*therapeutic use
Prostatic Neoplasms/*pathology
RANK Ligand/*antagonists & inhibitors
Adult ; Alendronate/adverse effects ; Alendronate/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Bisphosphonate-Associated Osteonecrosis of the Jaw/etiology ; Bone Density Conservation Agents/adverse effects ; Clodronic Acid/adverse effects ; Clodronic Acid/therapeutic use ; Denosumab/adverse effects ; Diphosphonates/adverse effects ; Etidronic Acid/adverse effects ; Etidronic Acid/therapeutic use ; Humans ; Male ; Network Meta-Analysis ; Pamidronate/adverse effects ; Pamidronate/therapeutic use ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Quality of Life ; Randomized Controlled Trials as Topic ; Risedronic Acid/adverse effects ; Risedronic Acid/therapeutic use ; Zoledronic Acid/adverse effects ; Zoledronic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
EGFR as a stable marker of prostate cancer dissemination to bones.
Autorzy :
Nastały P; Laboratory of Translational Oncology, Institute of Medical Biotechnology and Experimental Oncology, Medical University of Gdańsk, Gdańsk, Poland.; FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology (IFOM), Milan, Italy.
Stoupiec S; Department of Tumour Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Popęda M; Laboratory of Translational Oncology, Institute of Medical Biotechnology and Experimental Oncology, Medical University of Gdańsk, Gdańsk, Poland.
Smentoch J; Laboratory of Translational Oncology, Institute of Medical Biotechnology and Experimental Oncology, Medical University of Gdańsk, Gdańsk, Poland.
Schlomm T; Department of Urology, Charité University Hospital Berlin, Berlin, Germany.
Morrissey C; Department of Urology, University of Washington, Seattle, WA, USA.
Żaczek AJ; Laboratory of Translational Oncology, Institute of Medical Biotechnology and Experimental Oncology, Medical University of Gdańsk, Gdańsk, Poland.
Beyer B; Martini-Clinic, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tennstedt P; Martini-Clinic, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Graefen M; Martini-Clinic, Prostate Cancer Center and Section for Translational Prostate Cancer Research at the Clinic of Urology at University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Eltze E; Institute of Pathology Saarbruecken-Rastpfuhl, Saarbruecken, Germany.
Maiuri P; FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology (IFOM), Milan, Italy.
Semjonow A; Department of Urology, Prostate Center University Clinic Münster, Münster, Germany.
Pantel K; Department of Tumour Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Brandt B; University Medical Centre Schleswig-Holstein, Kiel, Germany.
Bednarz-Knoll N; Laboratory of Translational Oncology, Institute of Medical Biotechnology and Experimental Oncology, Medical University of Gdańsk, Gdańsk, Poland. .; Department of Tumour Biology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany. .
Pokaż więcej
Źródło :
British journal of cancer [Br J Cancer] 2020 Dec; Vol. 123 (12), pp. 1767-1774. Date of Electronic Publication: 2020 Sep 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*metabolism
Bone Neoplasms/*secondary
Neoplastic Cells, Circulating/*metabolism
Prostatic Neoplasms/*pathology
Biomarkers, Tumor/genetics ; Bone Neoplasms/mortality ; Cell Movement ; Collagen Type I/genetics ; Epithelial-Mesenchymal Transition ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Feasibility Studies ; Flow Cytometry ; Humans ; Immunohistochemistry ; Male ; Neoplastic Cells, Circulating/pathology ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Vimentin/metabolism
Czasopismo naukowe
Tytuł :
Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate.
Autorzy :
Janzen BW; Postgraduate Medical Education.
Ong A; Section of Radiation Oncology.
Penner M; Canadian Mennonite University, Winnipeg, MB, Canada.
Koul R; Section of Radiation Oncology.
Dubey A; Section of Radiation Oncology.
Ahmed S; Section of Radiation Oncology.
Bashir B; Section of Radiation Oncology.
Chowdhury A; Section of Radiation Oncology.
Dawe DE; Section of Hematology/Oncology, Department of Internal Medicine.; Section of Urology, Department of Surgery, Max Rady College of Medicine.
Nayak J; Section of Urology, Department of Surgery, Max Rady College of Medicine.
Kim JO; Section of Radiation Oncology.; Research Institute in Hematology and Oncology, CancerCare Manitoba, University of Manitoba.
Pokaż więcej
Źródło :
American journal of clinical oncology [Am J Clin Oncol] 2020 Dec 01; Vol. 43 (12), pp. 865-871.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma/*drug therapy
Androgen Antagonists/*therapeutic use
Antineoplastic Agents, Hormonal/*therapeutic use
Prostatic Neoplasms/*drug therapy
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Aged, 80 and over ; Humans ; Kallikreins/blood ; Male ; Manitoba/epidemiology ; Marital Status ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/therapy ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Radiation Oncologists ; Retrospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors.
Autorzy :
Tabrizi S; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: .
Alshalalfa M; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Radiation Oncology, University of California, San Francisco, California.
Mahal BA; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Davicioni E; Decipher Biosciences, San Diego, California.
Liu Y; Decipher Biosciences, San Diego, California.
Mouw KW; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Feng F; Department of Radiation Oncology, University of California, San Francisco, California.
Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Muralidhar V; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Nov 15; Vol. 108 (4), pp. 936-940. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*metabolism
Microtubule-Associated Proteins/*metabolism
Neoplasm Proteins/*metabolism
Neuroendocrine Tumors/*metabolism
Neuropeptides/*metabolism
Prostatic Neoplasms/*metabolism
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Confidence Intervals ; Humans ; Linear Models ; Male ; Neuroendocrine Tumors/mortality ; Neuroendocrine Tumors/pathology ; Prostate/metabolism ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/mortality ; Prostatic Neoplasms, Castration-Resistant/pathology ; Statistics, Nonparametric
Czasopismo naukowe
Tytuł :
Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC).
Autorzy :
Jonnalagadda B; Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Arockiasamy S; Department of Biomedical Sciences, Sri Ramachandra Institute of Higher Education and Research, Chennai, India. Electronic address: .
Krishnamoorthy S; Department of Urology, Sri Ramachandra Medical Centre, Sri Ramachandra Institute of Higher Education and Research, Chennai, India.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2020 Oct 15; Vol. 259, pp. 118208. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Receptors, Androgen/*metabolism
Androgens/metabolism ; Combined Modality Therapy/methods ; Disease Progression ; Drug Therapy, Combination/methods ; Humans ; Intercellular Signaling Peptides and Proteins/metabolism ; Male ; Prospective Studies ; Prostate/metabolism ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Receptors, Androgen/drug effects ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer.
Autorzy :
Nakanishi S; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan. .
Goya M; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
Tamaki M; Naha City Hospital, Naha, Okinawa, Japan.
Oshiro T; Naha City Hospital, Naha, Okinawa, Japan.
Saito S; Department of Urology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan.
Pokaż więcej
Źródło :
BMC research notes [BMC Res Notes] 2021 Jun 03; Vol. 14 (1), pp. 227. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Androgen Antagonists/therapeutic use ; Hormones ; Humans ; Male ; Neoplasm Grading ; Prostate-Specific Antigen ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Editorial Comment to Regional and facility disparities in androgen deprivation therapy for prostate cancer from a multi-institutional Japan-wide database.
Autorzy :
Hatakeyama S; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Ohyama C; Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 May; Vol. 28 (5), pp. 591-592. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Androgen Antagonists/adverse effects ; Androgens ; Antineoplastic Agents, Hormonal/therapeutic use ; Humans ; Japan/epidemiology ; Male
Opinia redakcyjna
Tytuł :
Systematic Literature Review of the Epidemiology of Advanced Prostate Cancer and Associated Homologous Recombination Repair Gene Alterations.
Autorzy :
Shore N; Carolina Urologic Research Center , Myrtle Beach, South Carolina.
Oliver L; Adelphi Values PROVE , Manchester, UK.
Shui I; Merck & Co.Inc., Kenilworth, New Jersey.
Gayle A; AstraZeneca , Cambridge, UK.
Wong OY; Adelphi Values PROVE , Manchester, UK.
Kim J; Merck & Co.Inc., Kenilworth, New Jersey.
Payne S; AstraZeneca , Cambridge, UK.
Amin S; AstraZeneca , Cambridge, UK.
Ghate S; Merck & Co.Inc., Kenilworth, New Jersey.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 977-986. Date of Electronic Publication: 2020 Dec 17.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Recombinational DNA Repair*
Biomarkers, Tumor/*genetics
Prostatic Neoplasms, Castration-Resistant/*epidemiology
Prostatic Neoplasms, Castration-Resistant/*genetics
Circulating Tumor DNA/genetics ; DNA Mutational Analysis ; Disease Progression ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Male ; Neoplasm Metastasis ; Prevalence ; Prognosis ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/pathology
Czasopismo naukowe
Tytuł :
Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role?
Autorzy :
Stonier T; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.; St George's Hospital, London, UK.
Tin AL; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Sjoberg DD; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Jibara G; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Vickers AJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Fine S; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Eastham J; Department of Surgery (Urology Service), Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1063-1068. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Patient Selection*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*surgery
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Grading ; Neoplasm Staging ; Prostatectomy ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk Factors ; Watchful Waiting
Czasopismo naukowe
Tytuł :
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
Autorzy :
Wibmer AG; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Chaim J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lakhman Y; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lefkowitz RA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nincevic J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Nikolovski I; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Sala E; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Gonen M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Carlsson SV; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Urology, Sahlgrenska Academy at University of Gothenburg, Institute of Clinical Sciences, Gothenburg, Sweden.
Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Zelefsky MJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
Scardino P; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Hricak H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1055-1062. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*therapy
Adult ; Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Prostatectomy ; Prostatic Neoplasms/mortality ; Radiotherapy ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł :
[TITAN study: evaluation of apalutamide in patients with metastatic hormone-sensitive prostate cancer - Treatment of metastatic hormone-sensitive prostate cancer (mHSPC)].
Autorzy :
Merseburger AS; Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Urology, Lübeck.
Suttmann H; Urologikum Hamburg, Standort Eppendorf, Hamburg.
Pokaż więcej
Transliterated Title :
TITAN-Studie – Evaluation von Apalutamid bei Patienten mit metastasiertem hormonsensitivem Prostatakarzinom.
Źródło :
Aktuelle Urologie [Aktuelle Urol] 2021 Apr; Vol. 52 (2), pp. 155-160. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms, Castration-Resistant*
Androgen Antagonists/adverse effects ; Hormones ; Humans ; Male ; Quality of Life ; Thiohydantoins
Czasopismo naukowe
Tytuł :
A novel tool for improving the interpretation of isotope bone scans in metastatic prostate cancer.
Autorzy :
Alshehri AHD; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.; Nuclear Medicine department, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Osman SOS; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.; Radiotherapy Physics, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Prise KM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.
Campfield C; Nuclear Medicine department, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Turner PG; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Jain SFP; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
O'Sullivan JM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Cole AJ; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Cancer Research and Cell Biology, Belfast, UK.; Clinical Oncology, Northern Ireland Cancer Centre, Belfast Health and Social Care Trust, Belfast, UK.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2020 Nov 01; Vol. 93 (1115), pp. 20200775. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Software Design*
Bone Neoplasms/*diagnostic imaging
Bone Neoplasms/*secondary
Bone and Bones/*diagnostic imaging
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Bone Neoplasms/pathology ; Bone Neoplasms/radiotherapy ; Etidronic Acid ; Humans ; Male ; Middle Aged ; Organotechnetium Compounds ; Prostatic Neoplasms, Castration-Resistant/pathology ; Radiopharmaceuticals ; Regression Analysis ; Tumor Burden ; Urinary Bladder/diagnostic imaging
Czasopismo naukowe
Tytuł :
Identification of crucial genes and pathways associated with prostate cancer in multiple databases.
Autorzy :
Guo H; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Zhang Z; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Wang Y; School of Clinical Medicine, Bengbu Medical College, Bengbu, China.
Xue S; Department of Urology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 Jun; Vol. 49 (6), pp. 3000605211016624.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Regulatory Networks*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Gene Ontology ; Humans ; Male ; Neoplasm Proteins/genetics ; Neoplasm Recurrence, Local ; Receptors for Activated C Kinase
Czasopismo naukowe
Tytuł :
Prostate Cancer Diagnosis and Management During One Year of the COVID-19 Pandemic.
Autorzy :
Pepe P; Urology Unit, Cannizzaro Hospital, Catania, Italy; .
Pepe L; Urology Unit, Cannizzaro Hospital, Catania, Italy.
Pennisi M; Urology Unit, Cannizzaro Hospital, Catania, Italy.
Fraggetta F; Pathology Unit, Cannizzaro Hospital, Catania, Italy.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Jun; Vol. 41 (6), pp. 3127-3130.
Typ publikacji :
Journal Article
MeSH Terms :
Pandemics*
COVID-19/*epidemiology
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*therapy
COVID-19/virology ; Humans ; Male ; Prostatic Neoplasms/pathology ; SARS-CoV-2/isolation & purification
Czasopismo naukowe
Tytuł :
[Betaine induces apoptosis of C4-2B prostate cancer cells via inhibiting PI3K/AKT/NF-κB signaling pathway].
Autorzy :
Zhang H; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004; Second People's Hospital of Luohe City, Luohe 462000, China.
Nie L; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Qin K; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Wang Z; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Yang B; Faculty of Physiology, School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Luo Y; Second People's Hospital of Luohe City, Luohe 462000, China.
Zhao R; Departmen of Urology, General Hospital of Ningxia Medical University, Yinchuan 750004, China. *Corresponding author, E-mail: .
Pokaż więcej
Źródło :
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology [Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi] 2021 Jun; Vol. 37 (6), pp. 513-519.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Proto-Oncogene Proteins c-akt*/genetics
Proto-Oncogene Proteins c-akt*/metabolism
Apoptosis ; Betaine ; Humans ; Male ; NF-kappa B/genetics ; NF-kappa B/metabolism ; Phosphatidylinositol 3-Kinase ; Phosphatidylinositol 3-Kinases/genetics ; Signal Transduction
Czasopismo naukowe
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Woo HH; Sydney Adventist Hospital, University of Sydney, Sydney, NSW.
Murphy DG; Peter MacCallum Cancer Centre, Melbourne, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 486-486.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Mark S; Christchurch Hospital, Christchurch, New Zealand.
Rashid P; University of New South Wales, Sydney, NSW.
Heathcote P; Australian Prostate Cancer Research Centre Queensland, Queensland University of Technology, Brisbane, QLD.
Zargar Shoshtari K; University of Auckland, Auckland, New Zealand.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 485-485.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Differences in treatment choices for localised prostate cancer diagnosed in private and public health services.
Autorzy :
Te Marvelde L; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC.
Milne RL; Cancer Council Victoria, Melbourne, VIC.; Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, VIC.
Haines IE; Cabrini Health, Melbourne, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Jun; Vol. 214 (10), pp. 486-486.e1. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Patient Selection ; Prostatectomy ; United States ; United States Public Health Service
Opinia redakcyjna
Tytuł :
Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.
Autorzy :
Khalvandi A; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Abolhasani M; Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Shekarabi M; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Kourosh-Arami M; Department of Neuroscience, School of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Mohsenzadegan M; Department of Medical Laboratory Science, Faculty of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2021 Jun; Vol. 129 (6), pp. 291-303. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, Neoplasm/*biosynthesis
Biomarkers, Tumor/*metabolism
Neoplasm Proteins/*biosynthesis
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Antigens, Neoplasm/analysis ; Biomarkers, Tumor/analysis ; Cell Nucleus/metabolism ; Humans ; Male ; Middle Aged ; Neoplasm Proteins/analysis ; Prognosis ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/mortality ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prognostic value of intraductal carcinoma for adjuvant radiotherapy candidates after radical prostatectomy.
Autorzy :
Karakoc S; Department of Urology, Dokuz Eylul University Hospital, Izmir, Turkey.
Celik S; Department of Urology, Dokuz Eylul University Hospital, Izmir, Turkey.
Kaya N; Department of Pathology, Dokuz Eylul University Hospital, Izmir, Turkey.
Bozkurt O; Department of Urology, Dokuz Eylul University Hospital, Izmir, Turkey.
Ellidokuz H; Institute of Oncology, Department of Preventive Oncology, Dokuz Eylul University Hospital, Izmir, Turkey.
Tuna B; Department of Pathology, Dokuz Eylul University Hospital, Izmir, Turkey.
Yorukoglu K; Department of Pathology, Dokuz Eylul University Hospital, Izmir, Turkey.
Mungan MU; Department of Urology, Dokuz Eylul University Hospital, Izmir, Turkey.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Jun; Vol. 75 (6), pp. e14099. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Intraductal, Noninfiltrating*/surgery
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Humans ; Male ; Neoplasm Recurrence, Local ; Prognosis ; Prostate ; Prostate-Specific Antigen ; Prostatectomy ; Radiotherapy, Adjuvant ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The Impact of Placement Errors on the Tumor Coverage in MRI-Guided Focal Cryoablation of Prostate Cancer.
Autorzy :
Moreira P; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St. Boston, 02115 Massachusetts, USA. Electronic address: .
Tuncali K; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St. Boston, 02115 Massachusetts, USA.
Tempany CM; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St. Boston, 02115 Massachusetts, USA.
Tokuda J; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St. Boston, 02115 Massachusetts, USA.
Pokaż więcej
Źródło :
Academic radiology [Acad Radiol] 2021 Jun; Vol. 28 (6), pp. 841-848. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Cryosurgery*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Humans ; Magnetic Resonance Imaging ; Male ; Needles ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer - a review of patent literature.
Autorzy :
Ha H; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Kwon H; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Lim T; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Jang J; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Park SK; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Byun Y; Department of Pharmacy, College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, South Korea.
Pokaż więcej
Źródło :
Expert opinion on therapeutic patents [Expert Opin Ther Pat] 2021 Jun; Vol. 31 (6), pp. 525-547. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*pharmacology
Glutamate Carboxypeptidase II/*antagonists & inhibitors
Prostatic Neoplasms/*drug therapy
Animals ; Antigens, Surface/metabolism ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacokinetics ; Drug Design ; Glutamate Carboxypeptidase II/metabolism ; Humans ; Male ; Molecular Targeted Therapy ; Neoplasm Metastasis ; Patents as Topic ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/pathology ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Hydrogel spacer shrinkage during external-beam radiation therapy following low-dose-rate brachytherapy for high-risk prostate cancer: a case series.
Autorzy :
Kubo K; Department of Radiation Oncology, Hiroshima University Hospital, 1-2-3 Kasumi Minami-ku Hiroshima-shi, Hiroshima, 734-8553, Japan. .
Kenjo M; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Kawabata H; Department of Radiation Oncology, Hiroshima Prefectural Hospital, 1-5-54 Ujinakanda Minami-ku Hiroshima-shi, Hiroshima, 734-0004, Japan.
Wadasaki K; Department of Radiation Oncology, Hiroshima Prefectural Hospital, 1-5-54 Ujinakanda Minami-ku Hiroshima-shi, Hiroshima, 734-0004, Japan.
Kajiwara M; Department of Urology, Hiroshima Prefectural Hospital, 1-5-54 Ujinakanda Minami-ku Hiroshima-shi, Hiroshima, 734-0004, Japan.
Doi Y; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Nakao M; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Miura H; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Ozawa S; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Nagata Y; Department of Radiation Oncology, Hiroshima University Hospital, 1-2-3 Kasumi Minami-ku Hiroshima-shi, Hiroshima, 734-8553, Japan.; Hiroshima High-Precision Radiotherapy Cancer Center, 2-2 Futabanosato Higashi-ku Hiroshima-shi, Hiroshima, 732-0057, Japan.
Pokaż więcej
Źródło :
Journal of medical case reports [J Med Case Rep] 2021 May 26; Vol. 15 (1), pp. 296. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article
MeSH Terms :
Brachytherapy*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Humans ; Hydrogels ; Male ; Radiotherapy Dosage ; Rectum/diagnostic imaging
Czasopismo naukowe
Tytuł :
Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.
Autorzy :
Andras I; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Cata ED; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Serban A; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Kadula P; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Telecan T; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Buzoianu M; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Bungardean M; Department of Pathology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Pathology, Emergency Country Hospital, 400006 Cluj-Napoca, Romania.
Stanca DV; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Coman I; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Crisan N; Department of Urology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Urology, Municipal Hospital, 400139 Cluj-Napoca, Romania.
Pokaż więcej
Źródło :
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 May 22; Vol. 57 (6). Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article
MeSH Terms :
Prostate*/diagnostic imaging
Prostate*/surgery
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Humans ; Image-Guided Biopsy ; Magnetic Resonance Imaging ; Male ; Neoplasm Grading ; Prostatectomy
Czasopismo naukowe
Tytuł :
Myasthenia gravis and prostatic neoplasia: a rare association.
Autorzy :
Pereira MS; Internal Medicine Department, Hospital Garcia de Orta, Almada, Portugal.
Escarigo MC; Internal Medicine Department, Hospital Garcia de Orta, Almada, Portugal.
Correia Azevedo P; Internal Medicine Department, Hospital Garcia de Orta, Almada, Portugal.
Delerue F; Internal Medicine Department, Hospital Garcia de Orta, Almada, Portugal .
Pokaż więcej
Źródło :
BMJ case reports [BMJ Case Rep] 2021 May 21; Vol. 14 (5). Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Blepharoptosis*
Myasthenia Gravis*/complications
Myasthenia Gravis*/diagnosis
Myasthenia Gravis*/drug therapy
Prostatic Neoplasms*/complications
Prostatic Neoplasms*/drug therapy
Aged, 80 and over ; Diplopia ; Humans ; Male ; Pyridostigmine Bromide/therapeutic use
Czasopismo naukowe
Tytuł :
A novel 1-((3-(2-toluyl)-4,5-dihydroisoxazol-5-yl)methyl)-4-(trifluoromethyl)pyrimidin-2(1H)-one activates intrinsic mitochondria-dependent pathway and decreases angiogenesis in PC-3 cells.
Autorzy :
Silva Dos Santos M; Department of Basic Health Sciences, Laboratory of Genetic Toxicology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Lobo MM; Chemical Core Heterocycles (NUQUIMHE), Chemistry Department, Federal University of Santa Maria, Santa Maria (UFSM), RS, Brazil.
Amaral SS; Department of Pharmacosciences, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Zanatta N; Chemical Core Heterocycles (NUQUIMHE), Chemistry Department, Federal University of Santa Maria, Santa Maria (UFSM), RS, Brazil.
Viau CM; Department of Basic Health Sciences, Laboratory of Genetic Toxicology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil. Electronic address: .
Saffi J; Department of Basic Health Sciences, Laboratory of Genetic Toxicology, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil. Electronic address: .
Pokaż więcej
Źródło :
European journal of pharmacology [Eur J Pharmacol] 2021 May 15; Vol. 899, pp. 174028. Date of Electronic Publication: 2021 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Neovascularization, Pathologic*
Angiogenesis Inhibitors/*pharmacology
Apoptosis/*drug effects
Mitochondria/*drug effects
Prostatic Neoplasms/*drug therapy
Pyrimidinones/*pharmacology
Ataxia Telangiectasia Mutated Proteins/metabolism ; DNA Damage ; Down-Regulation ; G2 Phase Cell Cycle Checkpoints/drug effects ; Histones/metabolism ; Humans ; Lipid Peroxidation/drug effects ; Male ; Membrane Potential, Mitochondrial/drug effects ; Mitochondria/metabolism ; Mitochondria/pathology ; PC-3 Cells ; Phosphorylation ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Reactive Oxygen Species/metabolism ; Signal Transduction ; Topoisomerase I Inhibitors/pharmacology ; Vascular Endothelial Growth Factor A/metabolism
Czasopismo naukowe
Tytuł :
Androgen signaling uses a writer and a reader of ADP-ribosylation to regulate protein complex assembly.
Autorzy :
Yang CS; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
Jividen K; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.
Kamata T; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
Dworak N; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.
Oostdyk L; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
Remlein B; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
Pourfarjam Y; Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA.
Kim IK; Department of Chemistry, University of Cincinnati, Cincinnati, OH, USA.
Du KP; Department of Radiation Oncology, University of Virginia, Charlottesville, VA, USA.
Abbas T; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.; Department of Radiation Oncology, University of Virginia, Charlottesville, VA, USA.
Sherman NE; W. M. Keck Biomedical Mass Spectrometry Laboratory, University of Virginia, Charlottesville, VA, USA.
Wotton D; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA.; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA.
Paschal BM; Center for Cell Signaling, University of Virginia, Charlottesville, VA, USA. .; Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 11; Vol. 12 (1), pp. 2705. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Protein Processing, Post-Translational*
Neoplasm Proteins/*genetics
Poly(ADP-ribose) Polymerases/*genetics
Prostatic Neoplasms/*genetics
Receptors, Androgen/*genetics
ADP-Ribosylation/drug effects ; Adenocarcinoma ; Antineoplastic Agents/pharmacology ; Cell Line, Tumor ; Humans ; Male ; Metribolone/pharmacology ; Neoplasm Proteins/metabolism ; Phthalazines/pharmacology ; Piperazines/pharmacology ; Poly (ADP-Ribose) Polymerase-1/genetics ; Poly (ADP-Ribose) Polymerase-1/metabolism ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology ; Poly(ADP-ribose) Polymerases/metabolism ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Receptors, Androgen/metabolism ; Signal Transduction ; Survival Analysis
Czasopismo naukowe
Tytuł :
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.
Autorzy :
Morka N; University College London Medical School, London, UK.
Simpson BS; UCL Division of Surgery & Interventional Science, University College London, London, UK.
Ball R; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, London, UK.
Freeman A; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, London, UK.
Kirkham A; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
Kelly D; School of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
Whitaker HC; UCL Division of Surgery & Interventional Science, University College London, London, UK.
Emberton M; UCL Division of Surgery & Interventional Science, University College London, London, UK.; Department of Urology, University College London Hospital, London, UK.
Norris JM; UCL Division of Surgery & Interventional Science, University College London, London, UK .; Department of Urology, University College London Hospital, London, UK.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 May 05; Vol. 11 (5), pp. e047664. Date of Electronic Publication: 2021 May 05.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Humans ; Magnetic Resonance Imaging ; Male ; Meta-Analysis as Topic ; Prostatectomy
Czasopismo naukowe
Tytuł :
The role of microRNA-572 in the proliferation and chemotherapeutic treatment of prostate cancer.
Autorzy :
Zang M; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of 12510Jilin University, Changchun City, Jilin Province, China.
Guo X; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of 12510Jilin University, Changchun City, Jilin Province, China.
Chen M; Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of 12510Jilin University, Changchun City, Jilin Province, China.
Pokaż więcej
Źródło :
The Journal of international medical research [J Int Med Res] 2021 May; Vol. 49 (5), pp. 3000605211014363.
Typ publikacji :
Journal Article
MeSH Terms :
MicroRNAs*/genetics
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/genetics
Apoptosis ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Neoplasm Invasiveness ; PTEN Phosphohydrolase/genetics ; PTEN Phosphohydrolase/metabolism
Czasopismo naukowe
Tytuł :
[Predictors for locoregional recurrence after radical prostatectomy].
Autorzy :
Petrovskij NV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Krupinov GE; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Amosov AV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Chinenov DV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
N GA; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Glybochko PV; Institute of Urology and Reproductive Health, FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
Pokaż więcej
Źródło :
Urologiia (Moscow, Russia : 1999) [Urologiia] 2021 May (2), pp. 100-105.
Typ publikacji :
Journal Article
MeSH Terms :
Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Prostate/pathology ; Prostatectomy
Czasopismo naukowe
Tytuł :
Carnobacterium inhibens isolated in blood culture of an immunocompromised, metastatic cancer patient: a case report and literature review.
Autorzy :
Lo CK; Division of Infectious Diseases, Juravinski Cancer Centre, McMaster University Infectious Diseases Residency Program, 699 Concession Street, Hamilton, Ontario, L8V 5C2, Canada. .
Sheth PM; Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, Canada. .; Division of Microbiology, Kingston Health Sciences Centre, 76 Stuart Street, Kingston, Ontario, K7L 2V7, Canada. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 May 01; Vol. 21 (1), pp. 403. Date of Electronic Publication: 2021 May 01.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Carnobacterium*/isolation & purification
Carnobacterium*/pathogenicity
Bacteremia/*microbiology
Gram-Positive Bacterial Infections/*drug therapy
Gram-Positive Bacterial Infections/*microbiology
Prostatic Neoplasms/*pathology
Aged, 80 and over ; Amoxicillin-Potassium Clavulanate Combination/therapeutic use ; Androgen Antagonists/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Bacteremia/drug therapy ; Blood Culture ; Canada ; Ceftriaxone/therapeutic use ; Food Microbiology ; Gram-Positive Bacterial Infections/blood ; Humans ; Immunocompromised Host ; Male ; Pneumonia, Bacterial/drug therapy ; Pneumonia, Bacterial/microbiology ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/microbiology ; Vancomycin/therapeutic use
SCR Organism :
Carnobacterium inhibens
Czasopismo naukowe
Tytuł :
Safety of image-guided radiotherapy in definitive radiotherapy for localized prostate cancer: a population-based analysis.
Autorzy :
Kuo YH; Department of Radiation Oncology, E-Da Hospital, Kaohsiung, Taiwan.
Liang JA; Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Chen GH; Department of Urology, China Medical University Hsinchu Hospital, Hsinchu, Taiwan.
Li CC; Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu, Taiwan.
Chien CR; Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.; Department of Radiation Oncology, China Medical University Hsinchu Hospital, Hsinchu, Taiwan.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 May 01; Vol. 94 (1121), pp. 20200456. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Adenocarcinoma/*mortality
Prostatic Neoplasms/*mortality
Radiotherapy, Image-Guided/*mortality
Adenocarcinoma/pathology ; Adenocarcinoma/radiotherapy ; Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/mortality ; Databases, Factual ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Probability ; Propensity Score ; Proportional Hazards Models ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy ; Radiotherapy, Image-Guided/adverse effects ; Radiotherapy, Image-Guided/methods ; Taiwan ; Young Adult
Czasopismo naukowe
Tytuł :
[Risk-adapted prostate cancer screening-update 2021].
Autorzy :
Al-Monajjed R; Medizinische Fakultät, Universitätsklinikum Düsseldorf, Klinik für Urologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland. .
Arsov C; Medizinische Fakultät, Universitätsklinikum Düsseldorf, Klinik für Urologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Albers P; Medizinische Fakultät, Universitätsklinikum Düsseldorf, Klinik für Urologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Pokaż więcej
Transliterated Title :
Risikoadaptierte Früherkennung des Prostatakarzinoms – Update 2021.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2021 May; Vol. 60 (5), pp. 592-601. Date of Electronic Publication: 2021 Apr 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Early Detection of Cancer ; Humans ; Male ; Mass Screening ; Middle Aged ; Randomized Controlled Trials as Topic ; Retrospective Studies
Czasopismo naukowe
Tytuł :
[Familial prostate cancer and genetic predisposition].
Autorzy :
Meissner VH; Klinik und Poliklinik für Urologie, Universitätsklinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
Jahnen M; Klinik und Poliklinik für Urologie, Universitätsklinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
Herkommer K; Klinik und Poliklinik für Urologie, Universitätsklinikum rechts der Isar, Fakultät für Medizin, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland. .
Pokaż więcej
Transliterated Title :
Familiäres Prostatakarzinom und genetische Prädisposition.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2021 May; Vol. 60 (5), pp. 567-575. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Genetic Predisposition to Disease*/genetics
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/genetics
Humans ; Incidence ; Male ; Mass Screening ; Prostate-Specific Antigen ; Risk Assessment
Czasopismo naukowe
Tytuł :
[Machine learning and multiparametric MRI for early diagnosis of prostate cancer].
Autorzy :
Bonekamp D; Abteilung für Radiologie (E010), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland. .
Schlemmer HP; Abteilung für Radiologie (E010), Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland.
Pokaż więcej
Transliterated Title :
Maschinelles Lernen und multiparametrische MRT in der Früherkennung des Prostatakarzinoms.
Źródło :
Der Urologe. Ausg. A [Urologe A] 2021 May; Vol. 60 (5), pp. 576-591. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Artificial Intelligence ; Early Detection of Cancer ; Humans ; Image-Guided Biopsy ; Machine Learning ; Magnetic Resonance Imaging ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
Autorzy :
Claps F; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.; Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Ramírez-Backhaus M; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Mir Maresma MC; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Gómez-Ferrer Á; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Mascarós JM; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Marenco J; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Collado Serra A; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Casanova Ramón-Borja J; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Calatrava Fons A; Department of Pathology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Trombetta C; Urological Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy.
Rubio-Briones J; Department of Urology, Valencian Oncology Institute Foundation, FIVO, Valencia, Spain.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 May; Vol. 28 (5), pp. 566-572. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article
MeSH Terms :
Laparoscopy*
Prostatic Neoplasms*/surgery
Humans ; Indocyanine Green ; Lymph Node Excision ; Lymph Nodes/surgery ; Male ; Pelvis/surgery ; Prostatectomy
Czasopismo naukowe
Tytuł :
Prostate Cancer Screening in Brazil: a single center experience in the public health system.
Autorzy :
de Oliveira RAR; Departamento de Uro-Oncologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil.; Divisão de Urologia, AC Camargo Cancer Center, São Paulo, SP, Brasil.
Guimarães GC; Serviço de Oncologia Cirúrgica, Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil.
Mourão TC; Departamento de Uro-Oncologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil.
Favaretto RL; Departamento de Uro-Oncologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil.
Santana TBM; Departamento de Uro-Oncologia, Hospital Beneficência Portuguesa de São Paulo, São Paulo, SP, Brasil.; Divisão de Urologia, AC Camargo Cancer Center, São Paulo, SP, Brasil.
Lopes A; Serviço de Cirurgia Pélvica do AC Camargo Cancer Center, São Paulo, SP, Brasil.
Zequi SC; Divisão de Urologia, AC Camargo Cancer Center, São Paulo, SP, Brasil.; Serviço de Cirurgia Pélvica do AC Camargo Cancer Center, São Paulo, SP, Brasil.
Pokaż więcej
Źródło :
International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2021 May-Jun; Vol. 47 (3), pp. 558-565.
Typ publikacji :
Journal Article
MeSH Terms :
Prostate-Specific Antigen*/analysis
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Adult ; Aged ; Aged, 80 and over ; Biopsy ; Brazil/epidemiology ; Early Detection of Cancer ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Public Health ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.
Autorzy :
Kwon DH; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, USA.
Vashisht R; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, USA.
Borno HT; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
Aggarwal RR; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
Small EJ; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
Butte AJ; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, USA.
Huang FW; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, USA; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, USA; San Francisco Veterans Affairs Medical Center, San Francisco, USA. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2021 May; Vol. 32 (5), pp. 678-679. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/epidemiology
Androgen Antagonists/therapeutic use ; Androgens/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Humans ; Male ; Registries ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Neglected side effects to curative prostate cancer treatments.
Autorzy :
Nolsøe AB; Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark.; Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
Jensen CFS; Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark.; Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
Østergren PB; Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark.; Department of Urology, Zealand University Hospital, Roskilde, Denmark.
Fode M; Department of Urology, Herlev and Gentofte Hospital, Herlev, Denmark. .; Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark. .; Department of Urology, Zealand University Hospital, Roskilde, Denmark. .
Pokaż więcej
Źródło :
International journal of impotence research [Int J Impot Res] 2021 May; Vol. 33 (4), pp. 428-438. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Erectile Dysfunction*/etiology
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/therapy
Humans ; Male ; Orgasm ; Prostatectomy/adverse effects ; Quality of Life
Czasopismo naukowe
Tytuł :
Sexual function and rehabilitation after radiation therapy for prostate cancer: a review.
Autorzy :
Nguyen DD; Faculty of Medicine, McGill University, Montreal, QC, Canada.
Berlin A; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network (UHN), University of Toronto, Toronto, ON, Canada.
Matthew AG; Division of Urology, University Health Network (UHN), University of Toronto, Toronto, ON, Canada.
Perlis N; Division of Urology, University Health Network (UHN), University of Toronto, Toronto, ON, Canada.
Elterman DS; Division of Urology, University Health Network (UHN), University of Toronto, Toronto, ON, Canada. .
Pokaż więcej
Źródło :
International journal of impotence research [Int J Impot Res] 2021 May; Vol. 33 (4), pp. 410-417. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Erectile Dysfunction*/etiology
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Sexual Dysfunction, Physiological*/etiology
Humans ; Male ; Prostatectomy ; Quality of Life
Czasopismo naukowe
Tytuł :
Laparoscopic Port-Site Metastasis From Prostate Cancer on 18F-Fluciclovine PET/CT.
Autorzy :
Tran G; From the Henry Ford Hospital, Detroit, MI.
Parrinello D; New York Institute of Technology College of Osteopathic Medicine at Arkansas State University, Jonesboro, AR.
Dalal I; From the Henry Ford Hospital, Detroit, MI.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 May 01; Vol. 46 (5), pp. e279-e281.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carboxylic Acids*
Cyclobutanes*
Laparoscopy*
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Aged ; Biopsy ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Prostatectomy ; Prostatic Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Hypogonadism and its treatment among prostate cancer survivors.
Autorzy :
Choi EJ; Department of Urology, University of California, Irvine Health, Orange, CA, USA.
Xu P; Department of Urology, University of California, Irvine Health, Orange, CA, USA.
El-Khatib FM; Department of Urology, University of California, Irvine Health, Orange, CA, USA.
Huynh LM; Department of Urology, University of California, Irvine Health, Orange, CA, USA.
Yafi FA; Department of Urology, University of California, Irvine Health, Orange, CA, USA. .
Pokaż więcej
Źródło :
International journal of impotence research [Int J Impot Res] 2021 May; Vol. 33 (4), pp. 480-487. Date of Electronic Publication: 2020 Dec 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cancer Survivors*
Hypogonadism*/drug therapy
Prostatic Neoplasms*/complications
Prostatic Neoplasms*/therapy
Adult ; Hormone Replacement Therapy ; Humans ; Male ; Testosterone/therapeutic use
Czasopismo naukowe
Tytuł :
[Research advances in the relationship of dietary factors and prostate cancer risk].
Autorzy :
Sun DQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lei L; Department of Cancer Prevention and Control, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Cai Y; School of Public Health, Peking University, Beijing 100191, China.
Li H; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Cao MM; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
He SY; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Yu XY; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Peng J; Department of Cancer Prevention and Control, Shenzhen Center for Chronic Disease Control, Shenzhen 518020, China.
Chen WQ; Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Pokaż więcej
Źródło :
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2021 Apr 23; Vol. 43 (4), pp. 443-448.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Dairy Products*
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/etiology
China ; Humans ; Male ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells.
Autorzy :
Chen CL; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan. .
Hsu SC; Institute of Biotechnology, National Tsing-Hua University, Hsinchu, Taiwan.; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.
Chung TY; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.
Chu CY; Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
Wang HJ; Institute of Medical Sciences, Tzu Chi University, Hualien City, Taiwan.
Hsiao PW; Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan.
Yeh SD; Department of Urology and Oncology, Taipei Medical University Hospital, Taipei, Taiwan.; Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Ann DK; Department of Diabetes and Metabolic Diseases Research, Irell & Manella Graduate School of Biological Sciences, Beckman Research Institute, City of Hope, Duarte, CA, USA.
Yen Y; Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Kung HJ; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan. .; Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan. .; Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan. .; Department of Biochemistry and Molecular Medicine, Comprehensive Cancer Center, University of California at Davis, Sacramento, CA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 Apr 23; Vol. 12 (1), pp. 2398. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arginine/*pharmacology
DNA-Binding Proteins/*genetics
Epigenesis, Genetic/*drug effects
Epigenomics/*methods
Gene Expression Regulation, Neoplastic/*drug effects
Muscle Proteins/*genetics
Oxidative Phosphorylation/*drug effects
Prostatic Neoplasms/*genetics
Transcription Factors/*genetics
Animals ; Arginine/metabolism ; Cell Line, Tumor ; Cell Nucleus/drug effects ; Cell Nucleus/metabolism ; DNA-Binding Proteins/metabolism ; Humans ; Male ; Mice ; Mitochondria/drug effects ; Mitochondria/genetics ; Mitochondria/metabolism ; Muscle Proteins/metabolism ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Signal Transduction/drug effects ; Signal Transduction/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Tytuł :
The Emerging Clinical Role of Spermine in Prostate Cancer.
Autorzy :
Peng Q; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Wong CY; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Cheuk IW; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Teoh JY; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Chiu PK; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Ng CF; SH Ho Urology Centre, Department of Surgery, The Chinese University of Hong Kong, Hong Kong, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 22; Vol. 22 (9). Date of Electronic Publication: 2021 Apr 22.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*drug therapy
Spermine/*metabolism
Animals ; Humans ; Male ; Prostatic Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study.
Autorzy :
Zhu J; Department of Oncology, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin.
Liang X; Department of Oncology, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin.
Wu D; Department of Oncology, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin.
Chen S; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Yang B; Department of Radiation Oncology, Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong, China.
Mao W; Department of Oncology, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin.
Shen D; Department of Oncology, the Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Apr 16; Vol. 100 (15), pp. e25237.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Neuroendocrine/*mortality
Carcinoma, Neuroendocrine/*pathology
Prostatic Neoplasms/*mortality
Prostatic Neoplasms/*pathology
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Carcinoma, Neuroendocrine/therapy ; Humans ; Incidence ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Prostatic Neoplasms/therapy ; SEER Program ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach.
Autorzy :
Kgatle MM; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Boshomane TMG; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Lawal IO; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Mokoala KMG; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Mokgoro NP; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Lourens N; Department of Urology, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Kairemo K; Departments of Molecular Radiotherapy & Nuclear Medicine, Docrates Cancer Center, 00180 Helsinki, Finland.; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zeevaart JR; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Radiochemistry, South African Nuclear Energy Corporation SOC (Necsa), Pelindaba 0001, South Africa.
Vorster M; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Sathekge MM; Department of Nuclear Medicine, University of Pretoria & Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Nuclear Medicine Research Infrastructure (NuMeRI), Steve Biko Academic Hospital, Pretoria 0001, South Africa.; Department of Nuclear Medicine, Steve Biko Academic Hospital, Pretoria 0001, South Africa.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 15; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immune Checkpoint Inhibitors/*therapeutic use
Prostatic Neoplasms/*drug therapy
Radioisotopes/*therapeutic use
Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Lymphocyte Activation/immunology ; Male ; Prostatic Neoplasms/immunology ; Prostatic Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer.
Autorzy :
Wang Y; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Xu L; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Shi S; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Wu S; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Meng R; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Chen H; School of Pharmacy, Guangdong Lingnan Institute of Technology, Guangzhou 510663, China.
Jiang Z; Department of Microbiology and Immunology, College of Basic Medicine and Public Hygiene, Jinan University, Guangzhou 510632, China.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 15; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Resistance, Neoplasm*/genetics
N-Glycosyl Hydrolases/*deficiency
Prostatic Neoplasms/*drug therapy
Androgen Antagonists/pharmacology ; Apoptosis/drug effects ; Ataxia Telangiectasia Mutated Proteins/metabolism ; Cell Cycle Checkpoints/drug effects ; Cell Line, Tumor ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Docetaxel/pharmacology ; Docetaxel/therapeutic use ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Male ; N-Glycosyl Hydrolases/genetics ; N-Glycosyl Hydrolases/metabolism ; Neoplasm Invasiveness ; Neurosecretory Systems/drug effects ; Neurosecretory Systems/metabolism ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology ; S Phase/drug effects
Czasopismo naukowe
Tytuł :
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand-1 staining: a retrospective study.
Autorzy :
Lin H; Department of Urinary Surgery, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
Liu Q; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
Zeng X; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China.
Yu W; Department of Orthopaedics, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China. .
Xu G; Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, No. 58, Zhongshan 2nd Road, Yuexiu District, Guangzhou, 510080, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Apr 13; Vol. 21 (1), pp. 399. Date of Electronic Publication: 2021 Apr 13.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents, Immunological/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Molecular Targeted Therapy ; Neoplasm Staging ; Phenylthiohydantoin/administration & dosage ; Phenylthiohydantoin/analogs & derivatives ; Prognosis ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; Prostatic Neoplasms, Castration-Resistant/diagnosis ; Prostatic Neoplasms, Castration-Resistant/metabolism ; Prostatic Neoplasms, Castration-Resistant/mortality ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Quo Vadis Advanced Prostate Cancer Therapy? Novel Treatment Perspectives and Possible Future Directions.
Autorzy :
Kvízová J; Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.; Bioinova, s.r.o., Vídeňská 1083, 140 20 Praha, Czech Republic.
Pavlíčková V; Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.
Kmoníčková E; Institute of Experimental Medicine of the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague, Czech Republic.
Ruml T; Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.
Rimpelová S; Department of Biochemistry and Microbiology, University of Chemistry and Technology, Technická 3, 166 28 Prague, Czech Republic.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Apr 12; Vol. 26 (8). Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostatic Neoplasms/*therapy
Animals ; Antineoplastic Agents, Hormonal/chemistry ; Antineoplastic Agents, Hormonal/pharmacology ; Antineoplastic Agents, Hormonal/therapeutic use ; Clinical Trials as Topic ; Combined Modality Therapy ; Humans ; Immunotherapy ; Male ; Phototherapy ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/immunology
Czasopismo naukowe
Tytuł :
Reference-free transcriptome signatures for prostate cancer prognosis.
Autorzy :
Nguyen HTN; Institute for Integrative Biology of the Cell, UMR 9198, CEA, CNRS, Université Paris-Saclay, Gif-Sur-Yvette, France.
Xue H; Institute for Integrative Biology of the Cell, UMR 9198, CEA, CNRS, Université Paris-Saclay, Gif-Sur-Yvette, France.
Firlej V; Institute of Biology, Université Paris Est Creteil, Creteil, Creteil, France.
Ponty Y; LIX CNRS UMR 7161, Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France.
Gallopin M; Institute for Integrative Biology of the Cell, UMR 9198, CEA, CNRS, Université Paris-Saclay, Gif-Sur-Yvette, France.
Gautheret D; Institute for Integrative Biology of the Cell, UMR 9198, CEA, CNRS, Université Paris-Saclay, Gif-Sur-Yvette, France. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Apr 12; Vol. 21 (1), pp. 394. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor*
Transcriptome*
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*mortality
Algorithms ; Computational Biology/methods ; Gene Expression Profiling ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Prognosis ; Prostatic Neoplasms/pathology ; Recurrence ; Reproducibility of Results ; Supervised Machine Learning
Czasopismo naukowe
Tytuł :
Prostate Adenocarcinoma with Brain Metastasis: A Surveillance, Epidemiology, and End Results Database Analysis 2010-2015.
Autorzy :
Myint ZW; Department of Internal Medicine, Division of Medical Oncology, University of Kentucky, Lexington, KY, USA.
Qasrawi AH; Department of Internal Medicine, Division of Medical Oncology, University of Kentucky, Lexington, KY, USA.
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2021 Apr 12; Vol. 27, pp. e930064. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article
MeSH Terms :
Brain/*pathology
Brain Neoplasms/*epidemiology
Prostatic Neoplasms/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Brain/diagnostic imaging ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Early Detection of Cancer ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Survival Analysis ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
Autorzy :
Vietri MT; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Via L. De Crecchio, 80138 Naples, Italy.; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
D'Elia G; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Caliendo G; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Resse M; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Casamassimi A; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Via L. De Crecchio, 80138 Naples, Italy.
Passariello L; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Albanese L; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Cioffi M; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Molinari AM; Department of Precision Medicine, University of Campania 'Luigi Vanvitelli', Via L. De Crecchio, 80138 Naples, Italy.; U.O.C. Clinical and Molecular Pathology, A.O.U. University of Campania 'Luigi Vanvitelli', 80138 Naple, Italy.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 04; Vol. 22 (7). Date of Electronic Publication: 2021 Apr 04.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Germ-Line Mutation*
Molecular Targeted Therapy*
Neoplasm Proteins*/genetics
Neoplasm Proteins*/metabolism
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/metabolism
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/prevention & control
Humans ; Male
SCR Disease Name :
Prostate cancer, familial
Czasopismo naukowe
Tytuł :
New approaches to targeting the androgen receptor pathway in prostate cancer.
Autorzy :
Velho PI; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.; Moinhos de Vento Hospital, Porto Alegre, Brazil.
Bastos DA; Sirio Libanes Hospital, Sao Paulo, Brazil.
Antonarakis ES; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.
Pokaż więcej
Źródło :
Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2021 Apr; Vol. 19 (4), pp. 228-240.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Androgen Receptor Antagonists/*therapeutic use
Antineoplastic Agents/*therapeutic use
Prostatic Neoplasms/*drug therapy
Receptors, Androgen/*metabolism
Signal Transduction/*drug effects
Androgen Receptor Antagonists/pharmacology ; Animals ; Antineoplastic Agents/pharmacology ; Humans ; Male ; Molecular Targeted Therapy/methods ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Testosterone/pharmacology ; Testosterone/therapeutic use
Czasopismo naukowe
Tytuł :
[Prostate cancer: When to treat, which treatment options by stage?]
Autorzy :
Ebner B; Urologische Klinik und Poliklinik, Campus Großhadern d. LMU München, München, Deutschland. .
Chaloupka M; Urologische Klinik und Poliklinik, Campus Großhadern d. LMU München, München, Deutschland.
Berg E; München, Deutschland.
Stief CG; Direktor der Urologischen Klinik, Campus Großhadern d. LMU München, München, Deutschland.
Kretschmer A; Urologische Klinik und Poliklinik, Klinikum Großhadern d. LMU München, München, Deutschland.
Herlemann A; Urologische Klinik und Poliklinik, Campus Großhadern d. LMU München, München, Deutschland.
Pokaż więcej
Transliterated Title :
Nicht metastasiertes Prostatakarzinom: Wann und wie behandeln?
Źródło :
MMW Fortschritte der Medizin [MMW Fortschr Med] 2021 Apr; Vol. 163 (7), pp. 36-40.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Prostate-Specific Antigen
Czasopismo naukowe
Tytuł :
[Advanced prostate cancer - modern therapies, better prognosis?]
Autorzy :
Westhofen T; München, Deutschland.
Chaloupka M; Urologische Klinik und Poliklinik, Campus Großhadern d. LMU München, München, Deutschland.
Herlemann A; Urologische Klinik und Poliklinik, Campus Großhadern d. LMU München, München, Deutschland.
Todenhöfer T; Studienpraxis Urologie, Nürtingen, Deutschland.
Stief CG; Direktor der Urologischen Klinik, Campus Großhadern d. LMU München, München, Deutschland.
Kretschmer A; Urologische Klinik und Poliklinik, Klinikum Großhadern d. LMU München, Marchionistr. 15, 81377, München, Deutschland. .
Pokaż więcej
Transliterated Title :
Neue Therapieoptionen beim fortgeschrittenen Prostatakarzinom.
Źródło :
MMW Fortschritte der Medizin [MMW Fortschr Med] 2021 Apr; Vol. 163 (7), pp. 41-43.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/therapy
Humans ; Male ; Prognosis
Czasopismo naukowe
Tytuł :
[It is unclear whether pelvic lymphadenectomy is of oncological benefit in prostate cancer].
Autorzy :
Weißbach L; GfM gGmbH Gesundheitsforschung für Männer, Urologie, Berlin.
Roloff C; GfM gGmbH Gesundheitsforschung für Männer, Allgemeinmedizin, Berlin.
Pokaż więcej
Transliterated Title :
Der onkologische Nutzen der pelvinen Lymphadenektomie ist beim Prostatakarzinom nicht geklärt.
Źródło :
Aktuelle Urologie [Aktuelle Urol] 2021 Apr; Vol. 52 (2), pp. 161-167. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
Humans ; Lymph Node Excision ; Lymph Nodes/pathology ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Prostatectomy
Czasopismo naukowe
Tytuł :
Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific Antigen Density in Pre-biopsy Detection of Clinically Insignificant Prostate Cancer.
Autorzy :
Sekito S; Department of Urology, Ise Red Cross Hospital, Ise, Japan .
Terabe T; Department of Urology, Ise Red Cross Hospital, Ise, Japan.
Shibahara T; Department of Urology, Ise Red Cross Hospital, Ise, Japan.
Onishi T; Department of Urology, Ise Red Cross Hospital, Ise, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 2183-2186.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostate-Specific Antigen/*analysis
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Biopsy, Large-Core Needle/methods ; Diffusion Magnetic Resonance Imaging ; Humans ; Image-Guided Biopsy ; Immunologic Tests ; Male ; Middle Aged ; Predictive Value of Tests ; Preoperative Care ; Prostate/pathology ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/metabolism ; Retrospective Studies ; Tumor Burden ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł :
Lowering and Stabilizing PSA Levels in Advanced-prostate Cancer Patients With Oral Methioninase.
Autorzy :
Han Q; AntiCancer, Inc., San Diego, CA, U.S.A.
Hoffman RM; AntiCancer, Inc., San Diego, CA, U.S.A. .
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 1921-1926.
Typ publikacji :
Clinical Trial; Journal Article
MeSH Terms :
Carbon-Sulfur Lyases/*administration & dosage
Prostate-Specific Antigen/*blood
Prostatic Neoplasms/*drug therapy
Administration, Oral ; Aged, 80 and over ; Bone Neoplasms/drug therapy ; Bone Neoplasms/secondary ; Disease Progression ; Down-Regulation/drug effects ; Enzyme Replacement Therapy ; Humans ; Male ; Methionine/blood ; Methionine/drug effects ; Middle Aged ; Pilot Projects ; Prostate-Specific Antigen/drug effects ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Recombinant Proteins/administration & dosage
Czasopismo naukowe
Tytuł :
How Much Daily Image-guided Volumetric Modulated Arc Therapy Is Useful for Proctitis Prevention With Respect to Static Intensity Modulated Radiotherapy Supported by Topical Medications Among Localized Prostate Cancer Patients?
Autorzy :
Ferini G; REM Radioterapia srl, Viagrande, Italy; .
Tripoli A; REM Radioterapia srl, Viagrande, Italy.
Molino L; Radiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Cacciola A; Radiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Lillo S; Radiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Parisi S; Radiation Oncology Unit - Department of Biomedical, Dental Science and Morphological and Functional Images, University of Messina, Messina, Italy.
Umina V; REM Radioterapia srl, Viagrande, Italy.
Illari SI; Fondazione Istituto Oncologico del Mediterraneo, Viagrande, Italy.
Marchese VA; REM Radioterapia srl, Viagrande, Italy.
Cravagno IR; Fondazione Istituto Oncologico del Mediterraneo, Viagrande, Italy.
Borzì GR; REM Radioterapia srl, Viagrande, Italy.
Valenti V; REM Radioterapia srl, Viagrande, Italy.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Apr; Vol. 41 (4), pp. 2101-2110.
Typ publikacji :
Journal Article
MeSH Terms :
Radiotherapy, Intensity-Modulated*/adverse effects
Radiotherapy, Intensity-Modulated*/methods
Anti-Inflammatory Agents/*administration & dosage
Proctitis/*prevention & control
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*radiotherapy
Administration, Topical ; Aged ; Aged, 80 and over ; Beclomethasone/administration & dosage ; Enema/methods ; Humans ; Hyaluronic Acid/administration & dosage ; Italy ; Male ; Middle Aged ; Organ Sparing Treatments/methods ; Proctitis/etiology ; Prostatic Neoplasms/pathology ; Radiation Dose Hypofractionation ; Radiation Injuries/prevention & control ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Image-Guided/adverse effects ; Radiotherapy, Image-Guided/methods ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The position of urethrovesical anastomosis after robotic radical prostatectomy assessed by MRI predicts early functional recovery: A cohort analyses from a randomized clinical trial.
Autorzy :
Regis L; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Salazar A; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Planas J; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Celma A; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Cuadras M; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Roche S; Department of Radiology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain. Electronic address: .
Mast R; Department of Radiology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain. Electronic address: .
Morote J; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Trilla E; Department of Urology, Vall d'Hebron University Hospital, Pg Vall d'Hebron 119, 08035, Barcelona, Spain; Universitat Autònoma de Barcelona, UAB, Campus de la UAB, Plaça Cívica, 08193, Bellaterra, Barcelona, Spain. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2021 Apr; Vol. 137, pp. 109589. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/surgery
Robotic Surgical Procedures*
Urinary Incontinence*/diagnostic imaging
Anastomosis, Surgical ; Humans ; Magnetic Resonance Imaging ; Male ; Prostatectomy ; Recovery of Function
Czasopismo naukowe
Tytuł :
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy.
Autorzy :
Klingebiel M; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Arsov C; University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany. Electronic address: .
Ullrich T; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Quentin M; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Al-Monajjed R; University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany. Electronic address: .
Mally D; University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany. Electronic address: .
Sawicki LM; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Hiester A; University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany. Electronic address: .
Esposito I; University Dusseldorf, Medical Faculty, Department of Pathology, D-40225 Dusseldorf, Germany. Electronic address: .
Albers P; University Dusseldorf, Medical Faculty, Department of Urology, D-40225 Dusseldorf, Germany. Electronic address: .
Antoch G; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Schimmöller L; University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2021 Apr; Vol. 137, pp. 109587. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Ultrasonography, Interventional*
Humans ; Image-Guided Biopsy ; Magnetic Resonance Imaging ; Male ; Prospective Studies
Czasopismo naukowe
Tytuł :
Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
Autorzy :
Kowa JY; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Soneji N; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Sohaib SA; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Mayer E; Department of Surgery, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.; Department of Surgery & Cancer, St Mary's Hospital Campus, Imperial College London, Praed Street, London, UK.
Hazell S; Department of Histopathology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Butterfield N; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Shur J; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Ap Dafydd D; Department of Radiology, The Royal Marsden NHS Foundation Trust, Chelsea, London, UK.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 Apr 01; Vol. 94 (1120), pp. 20201423. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging/*methods
Neoplasm Recurrence, Local/*diagnostic imaging
Neoplasm Recurrence, Local/*surgery
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*surgery
Aged ; Humans ; Male ; Middle Aged ; Prostate/diagnostic imaging ; Prostate/surgery ; Prostatectomy ; Prostatic Neoplasms/radiotherapy ; Retrospective Studies ; Salvage Therapy ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy to treat prostate cancer: A comparison of uro-oncology practice according to disease stage.
Autorzy :
Kinnaird W; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Kirby MG; Trends in Urology &, Men's Health, London, United Kingdom.
Mitra A; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Davda R; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Jenkins V; Sussex Health Outcomes Research and Education in Cancer, Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom.
Payne H; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Apr; Vol. 75 (4), pp. e13873. Date of Electronic Publication: 2020 Dec 28.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/radiotherapy
Sexual Dysfunction, Physiological*/etiology
Sexual Dysfunction, Physiological*/therapy
Androgen Antagonists/therapeutic use ; Androgens ; Humans ; Male ; Quality of Life
Czasopismo naukowe
Tytuł :
Role of Multiparametric Prostate Magnetic Resonance Imaging before Confirmatory Biopsy in Assessing the Risk of Prostate Cancer Progression during Active Surveillance.
Autorzy :
Salguero J; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain. .
Gómez-Gómez E; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Valero-Rosa J; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Carrasco-Valiente J; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Mesa J; Department of Radiology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Martin C; Department of Radiology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Campos-Hernández JP; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Rubio JM; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
López D; Department of Radiology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Requena MJ; Department of Urology, Reina Sofía University Hospital, IMIBIC, Cordoba University, Córdoba, Spain.
Pokaż więcej
Źródło :
Korean journal of radiology [Korean J Radiol] 2021 Apr; Vol. 22 (4), pp. 559-567. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms/*diagnosis
Aged ; Disease Progression ; Humans ; Logistic Models ; Male ; Middle Aged ; Neoplasm Grading ; Progression-Free Survival ; Prostate-Specific Antigen/analysis ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Risk
Czasopismo naukowe
Tytuł :
Relation between DIR recalculated dose based CBCT and GI and GU toxicity in postoperative prostate cancer patients treated with VMAT.
Autorzy :
Buranaporn P; Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Dankulchai P; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. Electronic address: .
Jaikuna T; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Prasartseree T; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Apr; Vol. 157, pp. 8-14. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Radiotherapy, Intensity-Modulated*/adverse effects
Spiral Cone-Beam Computed Tomography*
Cone-Beam Computed Tomography ; Humans ; Male ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Rectum/diagnostic imaging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patients.
Autorzy :
Shiota M; Department of Urology, Kyushu University, Fukuoka, Japan.
Terada N; Department of Urology, Miyazaki University, Miyazaki, Japan.
Saito T; Department of Urology, Niigata Cancer Center Hospital, Niigata, Japan.
Yokomizo A; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Kohei N; Department of Urology, Shizuoka General Hospital, Shizuoka, Japan.
Goto T; Department of Urology, Kyoto University, Kyoto, Japan.
Kawamura S; Department of Urology, Miyagi Cancer Center, Natori, Japan.
Hashimoto Y; Department of Urology, Hirosaki University, Hirosaki, Japan.
Takahashi A; Department of Urology, Hakodate Goryoukaku Hospital, Hakodate, Japan.
Kimura T; Department of Urology, Jikei University, Tokyo, Japan.
Tabata KI; Department of Urology, Kitasato University, Sagamihara, Japan.
Tomida R; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
Hashimoto K; Department of Urology, Sapporo Medical University, Sapporo, Japan.
Sakurai T; Department of Urology, Yamagata University, Yamagata, Japan.
Shimazui T; Department of Urology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Kasama, Japan.
Sakamoto S; Department of Urology, Chiba University, Chiba, Japan.
Kamiyama M; Department of Urology, University of Yamanashi Hospital, Chuo, Japan.
Tanaka N; Department of Urology, Nara Medical University, Kashihara, Japan.
Mitsuzuka K; Department of Urology, Tohoku University, Sendai, Japan.
Kato T; Department of Urology, Kagawa University, Kagawa, Japan.
Narita S; Department of Urology, Akita University, Akita, Japan.
Yasumoto H; Department of Urology, Shimane University, Izumo, Japan.
Teraoka S; Department of Urology, Tottori University, Yonago, Japan.
Kato M; Department of Urology, Nagoya University, Nagoya, Japan.
Osawa T; Department of Renal and Genitourinary Surgery, Hokkaido University, Sapporo, Japan.
Nagumo Y; Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan.
Matsumoto H; Department of Urology, Yamaguchi University, Ube, Japan.
Enokida H; Department of Urology, Kagoshima University, Kagoshima, Japan.
Sugiyama T; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kuroiwa K; Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.
Inoue T; Department of Urology, Kyoto University, Kyoto, Japan.
Mizowaki T; Department of Radiation Oncology & Image-Applied Therapy, Kyoto University, Kyoto, Japan.
Kamoto T; Department of Urology, Miyazaki University, Miyazaki, Japan.
Kojima T; Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan.
Kitamura H; Department of Urology, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan.
Sugimoto M; Department of Urology, Kagawa University, Kagawa, Japan.
Nishiyama H; Department of Urology, University of Tsukuba Hospital, Tsukuba, Japan.
Eto M; Department of Urology, Kyushu University, Fukuoka, Japan.
Pokaż więcej
Corporate Authors :
Japanese Urological Oncology Group (JUOG)
Źródło :
Cancer science [Cancer Sci] 2021 Apr; Vol. 112 (4), pp. 1524-1533. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article
MeSH Terms :
Hormones/*metabolism
Prostatic Neoplasms/*metabolism
Prostatic Neoplasms/*pathology
Aged ; Androgen Antagonists/therapeutic use ; Biopsy/methods ; Humans ; Japan ; Male ; Neoplasm Staging/methods ; Prognosis ; Progression-Free Survival ; Prostatic Neoplasms/drug therapy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy.
Autorzy :
Matsumoto K; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan. .
Niwa N; Department of Urology, Tokyo Saiseikai Central Hospital, Mita 1-4-17, Minato-ku, Tokyo, 108-0073, Japan.
Hagiwara M; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Kosaka T; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Takeda T; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Yasumizu Y; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Tanaka N; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Morita S; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Mizuno R; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Shinojima T; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Hara S; Department of Urology, Kawasaki Municipal Hospital, Shinkawadori 12-1, Kawasaki-ku, Kawasaki, 210-0013, Japan.
Asanuma H; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Oya M; Department of Urology, Keio University School of Medicine, Shinanomachi 35, Shinjuku-ku, Tokyo, 160-8582, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2021 Apr; Vol. 26 (4), pp. 744-752. Date of Electronic Publication: 2021 Jan 02.
Typ publikacji :
Journal Article
MeSH Terms :
Androgen Antagonists*/therapeutic use
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Androgens ; Follow-Up Studies ; Humans ; Male ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/radiotherapy ; Prostate-Specific Antigen ; Prostatectomy ; Retrospective Studies ; Salvage Therapy
Czasopismo naukowe
Tytuł :
Prostate Cancer Liver Metastases Presenting as Relatively Photopenic Lesions on 18F-Fluciclovine PET/CT.
Autorzy :
Baiomy A; From the Division of Diagnostic Imaging.
Martiniova L; Department of Experimental Therapeutics.
Efstathiou E; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Schuster DM
Ravizzini G; From the Division of Diagnostic Imaging.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 Apr 01; Vol. 46 (4), pp. e240-e241.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Carboxylic Acids*
Cyclobutanes*
Liver Neoplasms/*diagnostic imaging
Liver Neoplasms/*secondary
Prostatic Neoplasms/*pathology
Aged ; Humans ; Male ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography/methods ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/surgery ; Salvage Therapy
Czasopismo naukowe
Tytuł :
Editorial Comment to Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial.
Autorzy :
Haga N; Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Miyazaki T; Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Tsubouchi K; Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Okabe Y; Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 Apr; Vol. 28 (4), pp. 438-439. Date of Electronic Publication: 2021 Feb 07.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Brachytherapy*/adverse effects
Erectile Dysfunction*
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/radiotherapy
Humans ; Male ; Tadalafil/adverse effects
Opinia redakcyjna
Tytuł :
Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey.
Autorzy :
Rodin D; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Canada. Electronic address: .
Tawk B; German Cancer Research Consortium, Core Site Heidelberg, German Cancer Research Center, Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, Department of Radiation Oncology, Heidelberg Faculty of Medicine and Heidelberg University Hospital, Heidelberg, Germany.
Mohamad O; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, United States.
Grover S; Department of Radiation Oncology, University of Pennsylvania, Philadelphia, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
Moraes FY; Department of Oncology, Division of Radiation Oncology, Queen's University, Kingston, Canada.
Yap ML; Collaboration for Cancer Outcomes, Research and Evaluation (CCORE), Ingham Institute, UNSW Sydney, Liverpool, Australia; Liverpool and Macarthur Cancer Therapy Centres, Western Sydney University, Campbelltown, Australia.
Zubizarreta E; International Atomic Energy Agency, Vienna, Austria.
Lievens Y; Ghent University Hospital and Ghent University, Ghent, Belgium.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Apr; Vol. 157, pp. 32-39. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*
Radiotherapy, Intensity-Modulated*
Dose Fractionation, Radiation ; Humans ; Male ; Radiation Dose Hypofractionation ; Surveys and Questionnaires ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy.
Autorzy :
Kobayashi H; Department of Urology, Saiseikai Yokohamashi Tobu hospital, 3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama city, Kanagawa, 230-8765, Japan. .
Eriguchi T; Department of Radiation Oncology, Saiseikai Yokohamashi Tobu hospital, Yokohama city, Japan.
Tanaka T; Department of Radiation Oncology, Saiseikai Yokohamashi Tobu hospital, Yokohama city, Japan.
Ogata T; Department of Radiation Oncology, Saiseikai Yokohamashi Tobu hospital, Yokohama city, Japan.
Ishida M; Department of Urology, Saiseikai Yokohamashi Tobu hospital, 3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama city, Kanagawa, 230-8765, Japan.
Nakajima Y; Department of Urology, Saiseikai Yokohamashi Tobu hospital, 3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama city, Kanagawa, 230-8765, Japan.
Kumabe A; Department of Radiation Oncology, Saiseikai Yokohamashi Tobu hospital, Yokohama city, Japan.
Kosugi M; Department of Urology, Saiseikai Yokohamashi Tobu hospital, 3-6-1, Shimosueyoshi, Tsurumi-ku, Yokohama city, Kanagawa, 230-8765, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2021 Apr; Vol. 26 (4), pp. 736-743. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Radiosurgery*/adverse effects
Drug Tapering ; Humans ; Hydrogels ; Japan ; Male ; Organs at Risk ; Radiotherapy Dosage ; Rectum
Czasopismo naukowe
Tytuł :
Technical Note: ADAM PETer - An anthropomorphic, deformable and multimodality pelvis phantom with positron emission tomography extension for radiotherapy.
Autorzy :
Gillmann C; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Homolka N; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; Faculty for Physics and Astronomy, University of Heidelberg, Heidelberg, Germany.
Johnen W; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Runz A; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Echner G; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Pfaffenberger A; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Mann P; German Cancer Research Center (DKFZ), Department of Medical Physics in Radiation Oncology, Heidelberg, Germany.; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.
Schneider V; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hoffmann AL; OncoRay - National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Department for Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.
Troost EGC; OncoRay - National Center for Radiation Research in Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Department for Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiooncology - OncoRay, Dresden, Germany.; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany.
Koerber SA; Heidelberg Institute for Radiation Oncology (HIRO), National Center for Radiation Research in Oncology (NCRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Partner Site, Heidelberg, Germany.; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Kotzerke J; Department for Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.; Department for Nuclear Medicine, University Hospital Carl Gustav Carus, Dresden, Germany.
Beuthien-Baumann B; Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Partner Site, Heidelberg, Germany.
Pokaż więcej
Źródło :
Medical physics [Med Phys] 2021 Apr; Vol. 48 (4), pp. 1624-1632. Date of Electronic Publication: 2020 Dec 13.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Radiotherapy, Image-Guided*
Humans ; Magnetic Resonance Imaging ; Male ; Pelvis/diagnostic imaging ; Phantoms, Imaging ; Positron Emission Tomography Computed Tomography ; Positron-Emission Tomography
Czasopismo naukowe
Tytuł :
Automated contour propagation of the prostate from pCT to CBCT images via deep unsupervised learning.
Autorzy :
Liang X; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Bibault JE; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Leroy T; Department of Radiation Oncology, Clinique des Dentellières, Valenciennes, France.
Escande A; Department of Radiation Oncology, Oscar Lambret Cancer Center, Lille, France.
Zhao W; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Chen Y; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Buyyounouski MK; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Hancock SL; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Bagshaw H; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Xing L; Department of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Pokaż więcej
Źródło :
Medical physics [Med Phys] 2021 Apr; Vol. 48 (4), pp. 1764-1770. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Spiral Cone-Beam Computed Tomography*
Algorithms ; Cone-Beam Computed Tomography ; Humans ; Image Processing, Computer-Assisted ; Male ; Prostate/diagnostic imaging ; Radiotherapy Planning, Computer-Assisted ; Retrospective Studies ; Unsupervised Machine Learning
Czasopismo naukowe
Tytuł :
Family history of prostate cancer and prostate tumor aggressiveness in black and non-black men;results from an equal access biopsy study.
Autorzy :
Jenkins KR; Division of Urology, Veterans Affairs Medical Center, Durham, NC, USA.
Oyekunle T; Division of Urology, Veterans Affairs Medical Center, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Howard LE; Division of Urology, Veterans Affairs Medical Center, Durham, NC, USA.; Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.
Wiggins EK; Division of Urology, Veterans Affairs Medical Center, Durham, NC, USA.
Freedland SJ; Division of Urology, Veterans Affairs Medical Center, Durham, NC, USA.; Center for Integrated Research on Cancer and Lifestyle, Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, CA, USA.
Allott EH; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, 97 Lisburn Road, Room 2.15, Belfast, BT9 7AE, UK. .; Department of Histopathology and Morbid Anatomy, Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland. .
Pokaż więcej
Źródło :
Cancer causes & control : CCC [Cancer Causes Control] 2021 Apr; Vol. 32 (4), pp. 337-346. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/epidemiology
Prostatic Neoplasms*/ethnology
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/surgery
African Americans/*statistics & numerical data
Aged ; Biopsy ; Health Services Accessibility ; Humans ; Male ; Medical History Taking ; Middle Aged ; Neoplasm Grading
Czasopismo naukowe
Tytuł :
Lymph Node Assessment in Prostate Cancer: Evaluation of Iodine Quantification With Spectral Detector CT in Correlation to PSMA PET/CT.
Autorzy :
Lennartz S
Täger P; Department of Nuclear Medicine, Faculty of Medicine, University Cologne.
Zopfs D; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Iuga AI; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Reimer RP; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Zäske C; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Große Hokamp N; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Maintz D; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Heidenreich A; Department of Urology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Drzezga A; Department of Nuclear Medicine, Faculty of Medicine, University Cologne.
Kobe C; Department of Nuclear Medicine, Faculty of Medicine, University Cologne.
Persigehl T; From the Institute for Diagnostic and Interventional Radiology, Faculty of Medicine, University Cologne and University Hospital Cologne, Cologne, Germany.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 Apr 01; Vol. 46 (4), pp. 303-309.
Typ publikacji :
Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Antigens, Surface/*metabolism
Glutamate Carboxypeptidase II/*metabolism
Iodine Radioisotopes/*metabolism
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*pathology
Aged ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Prostatic Neoplasms/metabolism ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells.
Autorzy :
Soylu H; Department of Histology and Embryology, Faculty of Medicine, Duzce University, 81620 Duzce, Turkey.
Kırca M; Department of Biochemistry, Faculty of Medicine, Kutahya Health Sciences University, 43100 Kutahya, Turkey.
Avcı S; Department of Histology and Embryology, Faculty of Medicine, Alanya Alaaddin Keykubat University, 07070 Antalya, Turkey.
Ozpolat B; Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
Ustunel I; Department of Histology and Embryology, Faculty of Medicine, Akdeniz University, 07070 Antalya, TURKEY. Electronic address: .
Pokaż więcej
Źródło :
Experimental and molecular pathology [Exp Mol Pathol] 2021 Apr; Vol. 119, pp. 104607. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Androgen Antagonists/*pharmacology
Androstenes/*pharmacology
Docetaxel/*pharmacology
Jagged-1 Protein/*metabolism
Prostatic Neoplasms/*metabolism
Prostatic Neoplasms/*pathology
Receptor, Notch1/*metabolism
Transcription Factor HES-1/*metabolism
Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Male ; Neoplasm Metastasis ; Prostatic Neoplasms/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.
Autorzy :
Marnouche EA; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Hadadi K; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Abdelhak M; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Benlemlih M; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Hommadi M; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Zaghba N; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Andaloussi Saghir K; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Elmarjany M; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Sifat H; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Mansouri H; Department of Radiotherapy, Mohamed V Military Hospital, Rabat, Morocco. Electronic address: .
Pokaż więcej
Źródło :
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 Apr; Vol. 25 (2), pp. 161-168. Date of Electronic Publication: 2021 Jan 14.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*radiotherapy
Lymph Nodes/*diagnostic imaging
Prostate/*diagnostic imaging
Prostatic Neoplasms/*radiotherapy
Rectum/*diagnostic imaging
Urinary Bladder/*diagnostic imaging
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Algorithms ; Analysis of Variance ; Androgen Antagonists/therapeutic use ; Humans ; Iliac Artery/diagnostic imaging ; Iliac Vein/diagnostic imaging ; Lymph Nodes/anatomy & histology ; Lymphatic Irradiation/methods ; Male ; Organ Motion ; Organs at Risk/anatomy & histology ; Organs at Risk/diagnostic imaging ; Pelvic Bones/anatomy & histology ; Pelvic Bones/diagnostic imaging ; Pelvis ; Prospective Studies ; Prostate/anatomy & histology ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy Setup Errors ; Radiotherapy, Conformal ; Radiotherapy, Image-Guided ; Rectum/anatomy & histology ; Statistics, Nonparametric ; Tomography, X-Ray Computed ; Tumor Burden ; Urinary Bladder/anatomy & histology
Czasopismo naukowe
Tytuł :
Prospective dual-surrogate validation study of periodic imaging during treatment for accurately monitoring intrafraction motion of prostate cancer patients.
Autorzy :
Cetnar A; The Ohio State University, Department of Radiation Oncology, Columbus, United States. Electronic address: .
Ayan AS; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Graeper G; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Weldon M; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Woods K; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Klamer B; The Ohio State University, Department of Biomedical Informatics, Center for Biostatistics, Columbus, United States. Electronic address: .
Pan X; The Ohio State University, Department of Biomedical Informatics, Center for Biostatistics, Columbus, United States. Electronic address: .
Martin DD; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Diaz DA; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Gupta N; The Ohio State University, Department of Radiation Oncology, Columbus, United States.
Pokaż więcej
Źródło :
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Apr; Vol. 157, pp. 40-46. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/radiotherapy
Radiotherapy Planning, Computer-Assisted*
Fiducial Markers ; Humans ; Male ; Motion ; Movement ; Prospective Studies
Czasopismo naukowe
Tytuł :
Impact of low-dose tadalafil on adverse events after low-dose-rate brachytherapy for prostate cancer: A bi-center randomized open-label trial.
Autorzy :
Minagawa T; Department of Urology, Shinshu University, Matsumoto City, Nagano, Japan.
Oguchi T; Department of Urology, Nagano Municipal Hospital, Nagano City, Nagano, Japan.
Saitou T; Department of Urology, Shinshu University, Matsumoto City, Nagano, Japan.
Fukazawa A; Department of Radiology, Shinshu University, Matsumoto City, Nagano, Japan.
Hashida I; Department of Radiology, Nagano Municipal Hospital, Nagano City, Nagano, Japan.
Koiwai K; Department of Radiology, Shinshu University, Matsumoto City, Nagano, Japan.
Iijima K; Department of Urology, Nagano Municipal Hospital, Nagano City, Nagano, Japan.
Kato H; Department of Urology, Nagano Municipal Hospital, Nagano City, Nagano, Japan.
Ogawa T; Department of Urology, Shinshu University, Matsumoto City, Nagano, Japan.
Ishizuka O; Department of Urology, Shinshu University, Matsumoto City, Nagano, Japan.
Pokaż więcej
Źródło :
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2021 Apr; Vol. 28 (4), pp. 432-438. Date of Electronic Publication: 2021 Feb 07.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Brachytherapy*/adverse effects
Lower Urinary Tract Symptoms*/drug therapy
Lower Urinary Tract Symptoms*/etiology
Prostatic Hyperplasia*/drug therapy
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/radiotherapy
Drug Therapy, Combination ; Humans ; Male ; Sulfonamides/adverse effects ; Tadalafil/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical factors for predicting malignancy in patients with PSA < 10 ng/mL and PI-RADS 3 lesions.
Autorzy :
Sonmez G; Department of Urology, Erciyes University, Kayseri, Turkey.
Tombul ST; Department of Urology, Erciyes University, Kayseri, Turkey.
Demirtas T; Department of Medical History and Ethics, Erciyes University, Kayseri, Turkey.
Demirtas A; Department of Urology, Erciyes University, Kayseri, Turkey.
Pokaż więcej
Źródło :
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Apr; Vol. 17 (2), pp. e94-e99. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji :
Journal Article
MeSH Terms :
Magnetic Resonance Imaging/*methods
Prostate-Specific Antigen/*metabolism
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*diagnosis
Humans ; Male ; Middle Aged ; Prospective Studies ; Prostatic Neoplasms/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Comparing the clinical efficacy and safety of abiraterone and enzalutamide in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
Autorzy :
Wang X; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Yang H; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Hu X; Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Wang W; Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Yu X; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Wang S; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Zhang X; Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Liu L; Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2021 Apr; Vol. 27 (3), pp. 614-622. Date of Electronic Publication: 2020 Jun 12.
Typ publikacji :
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Androstenes/*therapeutic use
Phenylthiohydantoin/*analogs & derivatives
Prostatic Neoplasms, Castration-Resistant/*diagnosis
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Aged ; Androstenes/adverse effects ; Cohort Studies ; Humans ; Male ; Phenylthiohydantoin/adverse effects ; Phenylthiohydantoin/therapeutic use ; Progression-Free Survival ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinicopathological features to distinguish malignant solitary fibrous tumors of the prostate from prostatic stromal tumors.
Autorzy :
Xu Y; The Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.; The Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.
Li Z; The Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.
Shi J; The Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.
Fu Y; The Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.
Zhu L; The Department of Medical Imaging, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.
Fan X; The Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Zhongshan Road No. 321, Nanjing, 210008, China.
Foo WC; The Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA. .
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2021 Apr; Vol. 478 (4), pp. 619-626. Date of Electronic Publication: 2020 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*metabolism
Prostatic Neoplasms/*diagnosis
Prostatic Neoplasms/*pathology
Solitary Fibrous Tumors/*diagnosis
Solitary Fibrous Tumors/*pathology
Adult ; Aged ; Aged, 80 and over ; Diagnosis, Differential ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Phenotype ; Prostatic Neoplasms/metabolism ; Retrospective Studies ; Solitary Fibrous Tumors/metabolism ; Tumor Burden
Czasopismo naukowe
Tytuł :
Citrate activates autophagic death of prostate cancer cells via downregulation CaMKII/AKT/mTOR pathway.
Autorzy :
Fan X; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Zhou J; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Yan X; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Bi X; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Liang J; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Lu S; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China.
Luo L; State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, People's Republic of China. Electronic address: .
Zhou D; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, 200032 Shanghai, People's Republic of China. Electronic address: .
Yin Z; Jiangsu Province Key Laboratory for Molecular and Medical Biotechnology, College of Life Science, Nanjing Normal University, Nanjing, Jiangsu, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jun 15; Vol. 275, pp. 119355. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :
Journal Article
MeSH Terms :
Autophagic Cell Death/*drug effects
Calcium-Calmodulin-Dependent Protein Kinase Type 2/*metabolism
Citric Acid/*pharmacokinetics
Prostatic Neoplasms/*drug therapy
Proto-Oncogene Proteins c-akt/*metabolism
TOR Serine-Threonine Kinases/*metabolism
Animals ; Blotting, Western ; Cell Line, Tumor ; Down-Regulation ; Flow Cytometry ; Fluorescent Antibody Technique ; Humans ; Male ; Mice ; Mice, Inbred BALB C ; Neoplasm Transplantation ; PC-3 Cells ; Prostatic Neoplasms/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Prostate ultra-radical radiotherapy: reinventing the wheel.
Autorzy :
Sundar S; Nottingham University Hospitals NHS Trust, Nottingham NG5 1PB, UK. Electronic address: .
Symonds P; Department of Oncology, University of Leicester, Leicester, UK.
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2021 Jun; Vol. 22 (6), pp. e223.
Typ publikacji :
Letter; Comment
MeSH Terms :
Prostatic Neoplasms*/radiotherapy
Humans ; Male
Opinia redakcyjna
Tytuł :
[Active surveillance for patients with localized prostate cáncer. Adherence and protocol drop analysis.]
Autorzy :
Asensio SM; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España.
Virseda Rodríguez ÁJ; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Martín Izquierdo MM; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Radiodiagnóstico. Complejo Asistencial Universitario de Salamanca. España.
Herrero Polo M; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Coderque Mejía MP; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Rocha de Lossada A; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Hinchado Morgado S; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España.
Noya Mourullo A; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
García Gómez F; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Hernández Sánchez T; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Antúnez Plaza P; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Anatomía Patológica. Complejo Asistencial Universitario de Salamanca. España.
García García J; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Martín-Vallejo J; Departamento de Estadística. Facultad de Medicina. Universidad de Salamanca. España.
Gómez Veiga F; Grupo de Investigación Traslacional de Urología (GITUR-IBSAL). Instituto de Investigación Biomédica de Salamanca. España. Servicio de Urología. Complejo Asistencial Universitario de Salamanca. España.
Pokaż więcej
Transliterated Title :
La vigilancia activa en pacientes con cáncer de próstata localizado. Análisis de adherencia y salida del protocolo.
Źródło :
Archivos espanoles de urologia [Arch Esp Urol] 2021 Jun; Vol. 74 (5), pp. 477-487.
Typ publikacji :
Journal Article
MeSH Terms :
Prostatic Neoplasms*
Watchful Waiting*
Aged ; Biopsy ; Humans ; Male ; Prostate-Specific Antigen ; Risk Factors
Czasopismo naukowe
Tytuł :
Prostate Biparametric MRI: PI-RADS Committee Position and Perspectives.
Autorzy :
Scialpi M; Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy .
Scialpi P; Portogruaro Hospital, Venice, Italy.
Blasi AD; Tivoli Hospital, Tivoli, Italy.
Pokaż więcej
Źródło :
AJR. American journal of roentgenology [AJR Am J Roentgenol] 2021 Jun; Vol. 216 (6), pp. W32. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Letter; Comment
MeSH Terms :
Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Contrast Media ; Humans ; Image-Guided Biopsy ; Male
Opinia redakcyjna
Tytuł :
Letter to the Editor regarding "Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI".
Autorzy :
Ponsiglione A; Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy. Electronic address: .
Stanzione A; Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy.
Imbriaco M; Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy.
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2021 Jun; Vol. 139, pp. 109721. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Letter; Comment
MeSH Terms :
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Magnetic Resonance Imaging ; Male
Opinia redakcyjna
Tytuł :
Oligometastatic Bone Disease in Castration-Sensitive Prostate Cancer Patients Treated With Stereotactic Body Radiotherapy Using 68Ga-PSMA PET/CT: TROD 09-004 Study.
Autorzy :
Onal C; From the Department of Radiation Oncology, Adana Dr Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, Adana.
Ozyigit G; Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara.
Akgun Z; Division of Radiation Oncology, Memorial Sisli Hospital.
Atalar B; Department of Radiation Oncology, Acibadem MAA University Maslak Hospital.
Igdem S; Department of Radiation Oncology, Istanbul Bilim University, Istanbul.
Oymak E; Division of Radiation Oncology, Iskenderun Gelisim Hospital, Hatay.
Agaoglu F; Department of Radiation Oncology, Acibadem MAA University Atakent Hospital.
Selek U; Department of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey.
Guler OC; From the Department of Radiation Oncology, Adana Dr Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, Adana.
Hurmuz P; Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara.
Mustafayev TZ; Department of Radiation Oncology, Acibadem MAA University Maslak Hospital.
Akyol F; Department of Radiation Oncology, Hacettepe University Faculty of Medicine, Ankara.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 Jun 01; Vol. 46 (6), pp. 465-470.
Typ publikacji :
Journal Article
MeSH Terms :
Castration*
Oligopeptides*
Positron Emission Tomography Computed Tomography*
Radiosurgery*
Bone Neoplasms/*radiotherapy
Bone Neoplasms/*secondary
Edetic Acid/*analogs & derivatives
Prostatic Neoplasms/*pathology
Aged ; Bone Neoplasms/diagnostic imaging ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/surgery ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Effects of androgen deprivation therapy on cognitive functions in patients with metastatic prostate cancer: A multicentric, prospective study of the Society of Urological Surgery Andrology group.
Autorzy :
Cinar O; Department of Urology, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Turunc T; Urology Clinic, Iskenderun Gelisim Hospital, Iskenderun, Turkey.
Kazaz IO; Department of Urology, Karadeniz Technical University, Trabzon, Turkey.
Yildirim O; Department of Urology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.
Deliktas H; Department of Urology, Mugla Sitki Kocman University, Mugla, Turkey.
Cihan A; Department of Urology, Nigde Omer Halisdemir University, Nigde, Turkey.
Gudeloglu A; Department of Urology, Hacettepe University, Ankara, Turkey.
Ure I; Department of Urology, Eskisehir Osmangazi University, Eskisehir, Turkey.
Deveci S; Department of Urology, Istanbul Rumeli University, Istanbul, Turkey.
Sahin B; Department of Urology, Marmara University Medical Faculty, Istanbul, Turkey.
Cinar BP; Department of Neurology, Zonguldak Bulent Ecevit University, Zonguldak, Turkey.
Ozkara H; Department of Urology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Jun; Vol. 75 (6), pp. e14095. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji :
Journal Article
MeSH Terms :
Andrology*
Prostatic Neoplasms*/drug therapy
Androgen Antagonists/adverse effects ; Androgens ; Cognition ; Humans ; Male ; Prospective Studies
Czasopismo naukowe
Tytuł :
Quantitative Prostate MRI.
Autorzy :
Schieda N; Department of Medical Imaging, The Ottawa Hospital, Ottawa, Ontario, Canada.
Lim CS; Department of Medical Imaging, Sunnybrook Health Sciences, Toronto, Ontario, Canada.
Zabihollahy F; Faculty of Engineering, Carleton University, Ottawa, Ontario, Canada.
Abreu-Gomez J; Department of Medical Imaging, Sunnybrook Health Sciences, Toronto, Ontario, Canada.
Krishna S; Joint Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada.
Woo S; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Melkus G; Department of Medical Imaging, The Ottawa Hospital, Ottawa, Ontario, Canada.
Ukwatta E; Faculty of Engineering, Guelph University, Guelph, Ontario, Canada.
Turkbey B; Molecular Imaging Program, National Cancer Institute NIH, Bethesda, Maryland, USA.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2021 Jun; Vol. 53 (6), pp. 1632-1645. Date of Electronic Publication: 2020 May 15.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Diffusion Magnetic Resonance Imaging ; Humans ; Male ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Intracerebral Hemorrhaging Due to Coagulopathy Caused by Latent Advanced Prostate Cancer.
Autorzy :
Johno T; Department of Stroke and Cerebrovascular Medicine, Kyorin University, Japan.
Kawano H; Department of Stroke and Cerebrovascular Medicine, Kyorin University, Japan.
Hirokawa T; Department of Pathology, Kyorin University, Japan.
Shibahara J; Department of Pathology, Kyorin University, Japan.
Hirano T; Department of Stroke and Cerebrovascular Medicine, Kyorin University, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2021 Jun 01; Vol. 60 (11), pp. 1763-1767. Date of Electronic Publication: 2020 Dec 29.
Typ publikacji :
Journal Article
MeSH Terms :
Blood Coagulation Disorders*/etiology
Disseminated Intravascular Coagulation*
Prostatic Neoplasms*/complications
Cerebral Hemorrhage/etiology ; Humans ; Male ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
A multifaceted approach to quality in the MRI-directed biopsy pathway for prostate cancer diagnosis.
Autorzy :
Padhani AR; Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middlesex, HA6 2RN, UK. .
Schoots IG; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Radiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Turkbey B; Molecular Imaging Branch, NCI, NIH, Bethesda, MD, USA.
Giannarini G; Urology Unit, 'Santa Maria della Misericordia' Academic Medical Centre, Udine, Italy.
Barentsz JO; Department of Radiology, Nuclear Medicine & Anatomy, Radboud University Medical Center, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Jun; Vol. 31 (6), pp. 4386-4389. Date of Electronic Publication: 2020 Nov 25.
Typ publikacji :
Editorial
MeSH Terms :
Prostatic Neoplasms*/diagnostic imaging
Biopsy ; Humans ; Image-Guided Biopsy ; Magnetic Resonance Imaging ; Male
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies